technical analysis

But the charts show quiet accumulation building in Transocean and Schlumberger off lows.
It is all about the bearish setup, right now.
Valeant Pharmaceuticals' technicals look bullish with a strong base and support.
Both are potential reversals, with 15-20% upside.
The declines over the past week are unsustainable.
They aren't exactly sexy technology names, but a number of the drugstores have nice-looking charts.
There could be some decent upside left here.
Today may be a good opportunity to exit some names.
There is a time to pay up for stock, but that time is not now.
Keep a clear head and make your shopping list.

Columnist Conversations

A wild ride lies ahead. I am reducing my "Fair Market Value" of the S and P Index to 1835- four percent below ...
Today's Takeaways and Observations coming up - as I fly, like my Gnome, high above the Rockies!
As the market broke hard today we added some more puts on the indices and high flyers NFLX and AAPL. 1920 on ...
It's an ugly market today with the DJIA -400 and high beta stocks like $AMBA Ambarella down 7%. Oil and energy...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.